NH
Nihon Kohden Corporation
NHNKY · OTC
$9.65 -1.13% (-$0.11)
1M +1.69%
Market Cap ¥485.9B
P/E Ratio 35.41x
Div. Yield 1.87%
ROE 7.81%
Bulios Fair Price
$7.73
19.9% downside
Current Price
$9.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NHNKY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
41 /100
Fair P/B 2.76x
P/S 2.07x
P/E 35.41x
Growth
18 /100
Declining Book val. growth 4.71%
FCF growth 33.89%
EPS growth 15.01%
Profitability
53 /100
Moderate FCF margin 7.52%
Op. margin 7.02%
Gross margin 51.99%
Quality
42 /100
Average Asset turnover 0.96x
ROA 5.61%
ROIC 5.71%
Debt
100 /100
Low Net debt/EBITDA -1.11x
Int. coverage 51.79x
Debt/Equity 0.14x
Stability
86 /100
Stable Profitable years 6
EPS volatility 13.13%
Beta 0.38x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NHNKY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Hirokazu Ogino
Employees
6,116
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
09 NOV
Earnings
Upcoming earnings report
01 DEC
Dividend Payment
Payment date